Downregulated Tim‑3 expression is responsible for the incidence and development of colorectal cancer-Reference-Cited by-同舟云学术

Downregulated Tim‑3 expression is responsible for the incidence and development of colorectal cancer

Published:2018-05-11 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Zhang Ping¹,Wang Yan²,Liu Xue‑Rong³,Hong Shi‑Ru⁴,Yao Jian¹

Affiliation:

1. Department of Integrated Traditional Chinese Medicine and Western Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China

2. Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China

3. Department of Oncology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China

4. Department of Respiratory Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemical Expression of Immune Checkpoints; CTLA-4, LAG3, and TIM-3 in Cancer Cells and Tumor-infiltrating Lymphocytes (TILs) in Colorectal Carcinoma;Applied Immunohistochemistry & Molecular Morphology;2023-12-18

2. Immune regulation by activation markers at feto-maternal interface in infection-associated spontaneous preterm birth;Cytokine;2023-10

3. IL8 derived from macrophages inhibits CD8+ T-cell function by downregulating TIM3 expression through IL8-CXCR2 axis in patients with advanced colorectal cancer;International Immunopharmacology;2023-08

4. Occupational Low-Dose Radiation Affects the Expression of Immune Checkpoint of Medical Radiologists;International Journal of Environmental Research and Public Health;2022-06-09

5. The prognostic and clinicopathological significance of Tim-3 and PD-1 expression in the prognosis of upper urinary tract urothelial carcinoma;Urologic Oncology: Seminars and Original Investigations;2021-11